Robert J. Calcaterra
Directeur/Membre du Conseil chez Moleculera Labs, Inc.
Profil
Robert J.
Calcaterra is currently a Director at Moleculera Labs, Inc., Euclises Pharmaceuticals, Inc., Immunovalent Therapeutics, Inc., and Principal at Startup Midwest Management LLC.
He was previously President & CEO at Nidus Center for Scientific Enterprise, Director-Licensing, Research & Development at Adolph Coors Co., Director at Cardialen, Inc. and Galera Therapeutics, Inc., Research Engineer at Monsanto Co., and Senior Research Engineer at Amoco Corp.
He also served as President of St. Louis Arch Angels.
Calcaterra received his undergraduate and graduate degrees from the University of Nebraska and his doctorate from the University of Washington.
Postes actifs de Robert J. Calcaterra
| Sociétés | Poste | Début |
|---|---|---|
| Startup Midwest Management LLC | Corporate Officer/Principal | - |
Euclises Pharmaceuticals, Inc.
 Euclises Pharmaceuticals, Inc. Hospital/Nursing ManagementHealth Services Euclises Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm develops a portfolio of COX-2 inhibitors optimized for cancer treatment based on its proprietary Euclicoxib platform and is in the process of selecting a lead clinical development candidate. The company was founded by John J. Talley in 2011 and is headquartered in St. Louis, MO. | Directeur/Membre du Conseil | - |
Moleculera Labs, Inc.
 Moleculera Labs, Inc. Medical/Nursing ServicesHealth Services Moleculera Labs, Inc. provides clinical testing services for children and families suspected of suffering from Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal Infections (PANDAS)/Pediatric Acute-onset Neuropsychiatric Syndrome (PANS), which are treatable neurologic conditions that may be associated with motor tics, obsessive compulsive disorders, and sometimes Autism Spectrum Disorders. It offers its services to the physician as an aid in their diagnosis of PANDAS/PANS/Childhood Acute Neuropsychiatric Symptoms in parts of the United States. The company was founded by Madeleine Cunningham and Craig Shimasaki in 2011 and is headquartered in Oklahoma City, OK. | Directeur/Membre du Conseil | - |
Immunovalent Therapeutics, Inc.
 Immunovalent Therapeutics, Inc. BiotechnologyHealth Technology Immunovalent Therapeutics, Inc. is a medicine company harnessing microfluidic technology for the treatment of cancer immunotherapy. The company is headquartered in St. Louis, MO. | Directeur/Membre du Conseil | - |
Anciens postes connus de Robert J. Calcaterra
| Sociétés | Poste | Fin |
|---|---|---|
Nidus Center for Scientific Enterprise
 Nidus Center for Scientific Enterprise Miscellaneous Commercial ServicesCommercial Services Nidus Center for Scientific Enterprise provided business development services. The company was headquartered in St. Louis, MO. | Directeur Général | 01/01/2008 |
St. Louis Arch Angels
 St. Louis Arch Angels Investment ManagersFinance St. Louis Arch Angels provides seed and early stage capital to the startup organizations. Its members mentor and coach, serve on boards, provide contacts, assist with team building, strategic planning and fundraising. The company was founded by Gilbert Bickel in January 2005 and is headquartered in Saint Louis, MO. | President | - |
| Amoco Corp. | Corporate Officer/Principal | - |
| Adolph Coors Co. | Directeur Technique/Scientifique/R&D | - |
| MONSANTO | Corporate Officer/Principal | - |
Formation de Robert J. Calcaterra
| University of Nebraska | Graduate Degree |
| University of Washington | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GALERA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 10 |
|---|---|
Cardialen, Inc.
 Cardialen, Inc. Medical SpecialtiesHealth Technology Cardialen, Inc. develops medical devices. It offers pain-free cardio version therapy for atrial fibrillation (AF) using low-energy implantable atrial cardioverters. The firm develops and commercializes these as an independent specialist, to address major needs in atrial fibrillation management, achieve improved outcomes and reduce the risk of stroke, heart failure and high healthcare costs associated with atrial fibrillation. The company's products comprise implantable low-energy pain-free atrial cardioverters and cardiac leads and defibrillator equipment. Its products are used for the treatment of atrial and ventricular arrhythmias. Cardialen was founded in 2008 by D. Graeme Thomas, Randy H. Weiss and Igor R. Efimov and is headquartered in St. Louis, MO. | Health Technology |
| Startup Midwest Management LLC | |
Nidus Center for Scientific Enterprise
Nidus Center for Scientific Enterprise Miscellaneous Commercial ServicesCommercial Services Nidus Center for Scientific Enterprise provided business development services. The company was headquartered in St. Louis, MO. | Commercial Services |
Monsanto Co.
 Monsanto Co. Wholesale DistributorsDistribution Services Monsanto Co. engages in the provision of agricultural products to farmers. It provides other seed companies with genetic material and biotechnology traits for their seed brands. The company was founded by John F. Queeny in 1901 and is headquartered in St. Louis, MO. | Distribution Services |
| Adolph Coors Co. | Consumer Non-Durables |
| Amoco Corp. | Energy Minerals |
St. Louis Arch Angels
St. Louis Arch Angels Investment ManagersFinance St. Louis Arch Angels provides seed and early stage capital to the startup organizations. Its members mentor and coach, serve on boards, provide contacts, assist with team building, strategic planning and fundraising. The company was founded by Gilbert Bickel in January 2005 and is headquartered in Saint Louis, MO. | Finance |
Euclises Pharmaceuticals, Inc.
Euclises Pharmaceuticals, Inc. Hospital/Nursing ManagementHealth Services Euclises Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm develops a portfolio of COX-2 inhibitors optimized for cancer treatment based on its proprietary Euclicoxib platform and is in the process of selecting a lead clinical development candidate. The company was founded by John J. Talley in 2011 and is headquartered in St. Louis, MO. | Health Services |
Moleculera Labs, Inc.
Moleculera Labs, Inc. Medical/Nursing ServicesHealth Services Moleculera Labs, Inc. provides clinical testing services for children and families suspected of suffering from Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal Infections (PANDAS)/Pediatric Acute-onset Neuropsychiatric Syndrome (PANS), which are treatable neurologic conditions that may be associated with motor tics, obsessive compulsive disorders, and sometimes Autism Spectrum Disorders. It offers its services to the physician as an aid in their diagnosis of PANDAS/PANS/Childhood Acute Neuropsychiatric Symptoms in parts of the United States. The company was founded by Madeleine Cunningham and Craig Shimasaki in 2011 and is headquartered in Oklahoma City, OK. | Health Services |
Immunovalent Therapeutics, Inc.
Immunovalent Therapeutics, Inc. BiotechnologyHealth Technology Immunovalent Therapeutics, Inc. is a medicine company harnessing microfluidic technology for the treatment of cancer immunotherapy. The company is headquartered in St. Louis, MO. | Health Technology |
